TrialThe Journal of clinical investigation2023
A phase II study of Bruton's tyrosine kinase inhibition for the prevention of anaphylaxis.
Ragha V Suresh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it